HeartSciences Inc. (HSCSW)
NasdaqCM: HSCSW
· Precio en tiempo real · USD
0.04
+0.00 (0.00%)
Al cierre: Aug 06, 2026, 7:55 PM
HeartSciences Inc. (HSCSW) Stock Price, Analysis & Data
0.00% (1D)
No hay datos disponibles
| Precio de compra | n/a |
| Capitalización de mercado | n/a |
| Ingresos (TTM) | 4.32K |
| Beneficio neto (TTM) | -9.14M |
| Beta | 1.80 |
| EPS (TTM) | -1.09 |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | 0.57 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | n/a |
| Volumen | 12 |
| Volumen medio (20D) | |
| Abierto | 0.07 |
| Anterior Cerrar | 0.04 |
| Rango del día | 0.04 - 0.04 |
| Rango de 52 semanas | 0.04 - 0.04 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de HSCSW
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional EC...
IPO Fecha Jul 17, 2026
Empleados 14
Bolsa de Valores NasdaqCM
Símbolo bursátil HSCSW
Sitio web https://heartsciences.com
Desempeño financiero
En 2026, los ingresos de HeartSciences fueron 4.32K, una disminución de -0.71% en comparación con 4.35K del año anterior. Las ganancias fueron -9.14M, un aumento de 4.3%.
Estados financieros
